Harmony Biosciences Holdings, Inc. Announces Unaudited Consolidated Earnings Results for the Second Quarter and Six Months Ended June 30, 2021
August 10, 2021 at 08:00 am EDT
Harmony Biosciences Holdings, Inc. announced unaudited consolidated earnings results for the second quarter and six months ended June 30, 2021. For the quarter, the company reported net product revenues of $73,821,000 compared to $38,005,000 a year ago. Operating income was $23,312,000 compared to $7,309,000 a year ago. Net income and comprehensive income was $14,117,000 or $0.25 per basic share compared to loss of $27,000 or $1.34 per basic share a year ago. Diluted earnings per share was $0.24 compared to loss of $1.34 a year ago.
For the six months, the company reported net product revenues of $133,495,000 compared to $57,845,000 a year ago. Operating income was $37,844,000 compared to loss of $1,154,000 a year ago. Net income and comprehensive income was $21,503,000 or $0.38 per basic share compared to loss of $38,647,000 or $7.63 per basic share a year ago. Diluted earnings per share was $0.37 compared to loss of $7.63 a year ago.